BIMI Holdings Inc.

BIMI

US05552Q3011

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-15 pm EDT			5-day change	1st Jan Change
1.31 ^USD	+25.95%		-2.97%	-40.19%

Mar. 05	Top Premarket Decliners	MT
Jan. 05	BIMI International Medical, Inc. Announces Management Appointments	CI

BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 21, 2022 at 04:31 pm EST

BIMI International Medical, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 7.31 million compared to USD 13.78 million a year ago. Net loss was USD 3.71 million compared to USD 1.7 million a year ago. Basic loss per share from continuing operations was USD 1.6 compared to USD 3 a year ago.
For the nine months, sales was USD 17.26 million compared to USD 25.2 million a year ago. Net loss was USD 10.6 million compared to USD 5.31 million a year ago. Basic loss per share from continuing operations was USD 6.3 compared to USD 11.5 a year ago.

Latest news about BIMI Holdings Inc.

Top Premarket Decliners	Mar. 05	MT
BIMI International Medical, Inc. Announces Management Appointments	Jan. 05	CI
BIMI International Medical, Inc. has Changed its Name to BIMI Holdings Inc	Jan. 05	CI
BIMI International Medical, Inc. announced that it has received $3 million in funding	Jan. 01	CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 19	CI
BIMI International Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 22	CI
BIMI International Medical Gets Nasdaq Non-Compliance Notice for Late Quarterly Report	23-08-24	MT
Earnings Flash (BIMI) BIMI INTERNATIONAL MEDICAL Reports Q1 Revenue $3.2M	23-05-22	MT
BIMI International Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-19	CI
BIMI International Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-04	CI
BIMI International Medical, Inc. Auditor Raises 'Going Concern' Doubt	23-05-03	CI
BIMI International Medical Receives Non-Compliance Notice From Nasdaq	23-04-20	MT
BIMI International Medical Inc. Completed the acquisition of Phenix Bio Inc. from Fnu Oudom for $7.13 million.	23-03-14	CI
BIMI International Medical, Inc. announced that it expects to receive $3 million in funding	23-02-26	CI
Yu Xiang entered into an agreement to 87% stake in Chaohu Zhongshan Minimally Invasive Hospital from BIMI International Medical, Inc..	23-01-03	CI
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower	22-12-15	MT
Top Premarket Decliners	22-12-15	MT
BIMI International Medical Inc. cancelled the acquisition of Bengbu Mali Maternity Hospital from Renbao Chen and others.	22-12-14	CI
BIMI International Medical Climbing in Late Trade After Contingent Payments From 2020 Purchase Returned	22-12-13	MT
BIMI International to Effect 1-for-10 Reverse Stock Split; Shares Rise After-Hours	22-12-08	MT
BIMI International Medical, Inc. announced that it has received $2 million in funding	22-12-05	CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
BIMI International Medical, Inc. cancelled the transaction announced on November 17, 2021	22-11-16	CI
BIMI International Agrees to Sell Chonqing Zhuoda Pharmaceutical in China; to Focus on Growth in US	22-10-24	MT
Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc..	22-10-23	CI

Chart BIMI Holdings Inc.

Duration

Period

More charts

Company Profile

BIMI Holdings Inc., formerly BIMI International Medical Inc., is a healthcare products and services provider. The Company offers a range of healthcare products and related services in the United States and Asia. The Company operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.

Sector

Pharmaceuticals

Calendar

2024-05-15 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
BIMI HOLDINGS INC.	-40.19%	18.34M
MCKESSON CORPORATION	+12.89%	68.68B
CARDINAL HEALTH, INC.	+6.18%	26.03B
SINOPHARM GROUP CO. LTD.	-4.45%	7.86B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+3.53%	7.94B
HUADONG MEDICINE CO., LTD	-28.85%	7.13B
H. LUNDBECK A/S	+0.79%	4.59B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+19.12%	4.39B
EBOS GROUP LIMITED	0.00%	4.06B
GALENICA AG	-3.37%	3.85B